Molecular Aspects of Signal Transduction in Endocrine Tissue

Berridge MJ . Inositol triphosphate and calcium signalling. Nature 1993; 361: 315–25.

Schlessinger J Ullrich A . Growth factor signalling by receptor tyrosine kinases. Neuron 1992; 9: 383–91.

Linder ME Gilman AG . G proteins. Sci Am 1992; 267 (1): 36–43.

Sternweis PC Smrcka AV . Regulation of phospholipase C by G proteins. Trends Biochem Sci 1992; 17: 502–6.

Houslay MD . G-protein-linked receptors: A family probed by molecular cloning and mutagenesis procedures. Clin Endocrinol 1992; 36: 525–34.

Logothetis DE Kurachi Y Galper J Neer EJ Clapham DE . The β-subunit and γ subunit of GTP-binding proteins activate the muscarinic K⁺ channel in heart. Nature 1987; 325: 321–6.

Clapham DE Neer EJ . New roles for G-protein βγ-dimers in transmembrane signalling. Nature 1993; 365: 403–6.

Kababian JW Calme DB . Multiple receptors for dopamine. Nature 1979; 277: 93–6.

Vallar L Meldolesi J . Mechanism of signal transduction at the dopamine D2 receptor. Trends Pharmacol Sci 1989; 10: 74–7.

Wood DF Johnston JM Johnston DG . Dopamine, the D2 receptor and pituitary tumours. Clin Endocrinol 1991; 35: 455–66.

Taylor SS Buechler JA Yonemoto W . cAMP-dependent protein kinase: Framework for a diverse family of regulatory enzymes. Ann Rev Biochem 1990; 59: 971–1005.

Berridge MJ . A tale of two messengers. Nature 1993; 365: 388–9.

Hallam TJ Rink TJ . Receptor mediated calcium entry: Diversity of function and mechanism. Trends Pharmacol Sci 1989; 10: 8–11.

Tsien RW Tsien RY . Calcium channels, stores and oscillations. Ann Rev Cell Biol 1990; 6: 715–60.

Mitchell PG Tjian R . Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 1989; 245: 371–8.

Roesler WJ Vanderbard GR Hanson RW . Cyclic AMP and the induction of eukaryotic gene expression. J Biol Chem 1988; 263: 9063–6.

Schmid W Nitsch D Boshart M Schütz G . Role of cyclic AMP in the control of cell-specific gene expression. Trends Endocrinol Metab 1993; 4: 204–9.

Nishizuka Y . The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984; 308: 693–8.

Montminy MR Bilezikjian LM . Binding of a nuclear protein to the cyclic AMP response element of the somatostatin gene. Nature 1987; 328: 175–8.

Hoeffler JP Meyer TE Yun Y Jameson JL Habener JF . Cyclic AMP-responsive DNA-binding protein: Structure based on a cloned placental cDNA. Science 1988; 242: 1430–3.

Karin M Smeal T . Control of transcription factors by signal transduction pathways: At the begininning of the end. Trends Biochem Sci 1992; 17: 418–22.

Nielsen DA Shapiro DJ . Insights into hormonal control of messenger RNA stability. Mol Endocrinol 1990; 4: 953–7.

Krishnan AV Feldman D . Cyclic AMP up-regulates 1,25-dihydroxyvitamin D₃ receptor gene expression and enhances hormone action. Mol Endocrinol 1992; 6: 198–206.

Evans RM . The steroid and thyroid-hormone receptor superfamily. Science 1988; 240: 889–95.

Beato M . Gene regulation by steroid hormones. Cell 1989; 56: 335–44.

Rhodes D Klug A . Zinc fingers. Sci Am 1993; 268(2): 32–9.

Green S Chambon P . Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 1988; 4: 309–14.

Zhang X Pfahl M . Regulation of retinoid and thyroid hormone action through homodimeric and heterodimeric receptors. Trends Endocrinol Metab 1993; 4: 156–62.

Forman BM Samuels HH . Interactions among a subfamily of nuclear hormone receptors: The regulatory zipper model. Mol Endocrinol 1990; 4: 1293–1301.

Bodnes M Castrillo J-L Theill LE Deerinck T Ellisman M Karin M . The pituitary specific transcription factor GHF-1 is a homeobox-containing protein. Cell 1988; 55: 505–18.

Fox SR Jong MTC Casonova K Ye ZS Stanley F Samuels HH . The homeodomain protein, Pit-1/GHF-1, is capable of binding to and activating cell-specific elements of both the growth hormone and prolactin gene promoters. Mol Endocrinol 1990; 4: 1069–80.

Castrillo J-L Theill L Karin M . Function of the homeodomain protein GHF-1 in pituitary cell proliferation. Science 1991; 253: 197–9.

Jameson JL Arnold A . Recombinant DNA strategies for determining the molecular basis of endocrine disorders. J Clin Endocrinol Metab 1990; 70: 301–7.

Jameson JL Hollenberg AN . Recent advances in studies of the molecular basis of endocrine disease. Horm Metab Res 1992; 24: 201–9.

Vnencak JCL Phillips JA Chen EY Seeburg PH . Molecular basis of human growth hormone deletions. Proc Natl Acad Sci USA 1988; 85: 5615–19.

Steiner DF Tager HS Chan SJ Nanjo K Sanke T Rubenstein AH . Lessons learned from molecular biology of insulin gene mutations. Diabetes Care 1990; 13: 600–9.

Arnold A Horst SA Gardella TJ Baba H Levine MA Kronenberg HM . Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest 1990; 86: 1084–7.

Weiss J Axelrod L Whitcomb RW Harris PE Crowley WF Jameson JL . Hypogonadism caused by a single amino acid substitution in the β subunit of luteinising hormone. N Engl J Med 1992; 326: 179–83.

Petterson K Ding Y -Q Huhtaniemi I . An immunologically anomalous luteinising hormone variant in a healthy woman. J Clin Endocrinol Metab 1992; 74: 164–71.

Davies K . Diabetes defect defined. Nature 1992; 359: 434.

Lefkowitz RJ . Turned on to ill effect. Nature 1993; 365: 603–4.

Shenker A Laue L Kosugi S Merendino JJ Jr Minegishi T Cutler GB Jr A constitutively activating mutation of the luteinising hormone receptor in familial male precocious puberty. Nature 1993; 365: 652–4.

Parma J Duprez L Van Sande J Cochaux P Gervy C Mockel D Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993; 365: 649–51.

Vallar L Spada A Giannattasio G . Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 1987; 330: 566–8.

Lyons J Landis CA Harsh G Vallar L Grunewald K Feichtinger H Two G protein oncogenes in human endocrine tumours. Science 1990; 249: 655–9.

Schwindinger WF Francomano CA Levine MA . Identification of a mutation in the gene encoding the α-subunit of the stimulatory G-protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 1992; 89: 5152–6.

O'Sullivan C Barton CM Staddon SL Brown CL Lemoine NR . Activating point mutations in the gsp oncogene in human thyroid adenomas. Mol Carcinog 1991; 4: 345–8.

McGinley JI Canavatchel WJ . Complete androgen insensitivity, pathophysiology, diagnosis and management. Trends Endocrinol Metab 1992; 3: 75–80.

McPhaul MJ Marcelli M Zoppi S Griffin JE Wilson JD . The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab 1993; 76: 17–23.

Usala SJ Weintraub BD . Thyroid hormone resistance syndromes. Trends Endocrinol Metab 1991; 2: 140–4.

Jameson JL . Thyroid hormone resistance: Pathophysiology at the molecular level [Editorial]. J Clin Endocrinol Metab 1992; 74: 708–11.

Refetoff S Weiss RE Usala SJ . The syndromes of resistance to thyroid hormone. Endocr Rev 1993; 14: 348–99.

Hughes MR Malloy PJ Kieback DG Kesterson RA Pike JW Feldman D Point mutation in the human vitamin D receptor gene associated with hypocalcaemic rickets. Science 1988; 242: 1702–5.

Brandon DD Markwick AJ Chrousos GP Loriaux DL . Glucocorticoid resistance in humans and nonhuman primates. Cancer Res 1989; 49:2203s–13s.

Radovick S Nations M Du Y Berg LA Weintraub BD Wondisford FE . A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 1992; 257: 1115–18.

Pfäffle RW DiMattia GE Parks JS Brown MR Wit JM Jansen M Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992; 257: 1118–21.

Parks JS Kinoshita E-I Pfäffle RW . Pit-1 and hypopituitarism. Trends Endocrinol Metab 1993; 4: 81–5.